Related Experiment Videos
Macrophage migration inhibitory factor: an emerging therapeutic target in rheumatoid arthritis
Eric F Morand1, Richard Bucala, Michelle Leech
1Monash Medical Centre, Clayton, Melbourne, Victoria, Australia. eric.morand@med.monash.edu.au
Arthritis and Rheumatism
|February 7, 2003
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Off-licence use of clozapine: Lessons from an inner-city NHS trust - Comparison with other NHS Trusts.
Schizophrenia research·2026
Dosimetric and Clinical Impact of Bone Marrow-sparing Radiation Therapy for Anal Cancer: A Systematic Review.
Advances in radiation oncology·2026
High disease activity persists in adults with childhood-onset lupus.
Lupus science & medicine·2026
Optimising survivorship care in Hodgkin's lymphoma: Aligning practice with Ireland's AYA cancer framework.
Journal of cancer policy·2026
Regional distribution of adult rheumatologists.
Arthritis and rheumatism·2013
Clinically significant renal involvement in primary Sjögren's syndrome: clinical presentation and outcome.
Arthritis and rheumatism·2013
Headache in systemic lupus erythematosus: results from a prospective, international inception cohort study.
Arthritis and rheumatism·2013
Fatty Acid Metabolic Reprogramming in Rheumatoid Arthritis: Integrating Inflammation, Resolution Failure, and Joint Destruction.
Journal of inflammation research·2026
Sporadic lymphangioleiomyomatosis with lymphocyte-predominant pleural effusion misdiagnosed as tuberculosis: a case report.
Respiratory medicine case reports·2026
Epitope-Specific Thyroid Peroxidase Antibodies Reveal Functional Heterogeneity Within a Patient-Derived Monoclonal Repertoire.
Clinical and experimental immunology·2026